3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 0 0 0 0 0 0999 V2000
2.8449 -0.3996 0.0218 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7015 0.9540 -0.2189 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8096 0.3031 0.0726 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4213 0.7371 0.0860 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1256 -1.0131 -0.2641 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8248 1.2028 0.3971 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6055 0.1273 -0.5491 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0165 0.6206 -0.5184 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4568 -1.4296 -0.2765 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1560 0.7865 0.3849 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4719 -0.5299 0.0480 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1760 -0.0989 0.1164 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9217 -1.2604 0.7002 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2134 1.6417 0.6540 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3356 0.8478 -1.5422 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1072 1.5278 0.0904 H 0 0 0 0 0 0 0 0 0 0 0 0
0.4429 -0.7606 -1.1532 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3680 -1.7535 -0.5037 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 2.2330 0.6611 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.7031 -2.4556 -0.5340 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.9468 1.4869 0.6376 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.5084 -0.8543 0.0396 H 0 0 0 0 0 0 0 0 0 0 0 0
4.8118 -2.1341 0.0529 H 0 0 0 0 0 0 0 0 0 0 0 0
4.5463 -1.4747 1.7039 H 0 0 0 0 0 0 0 0 0 0 0 0
5.9842 -1.0107 0.7714 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 1 0 0 0 0
1 12 1 0 0 0 0
2 12 2 0 0 0 0
3 4 1 0 0 0 0
3 5 2 0 0 0 0
3 6 1 0 0 0 0
4 7 2 0 0 0 0
4 14 1 0 0 0 0
5 9 1 0 0 0 0
5 18 1 0 0 0 0
6 10 2 0 0 0 0
6 19 1 0 0 0 0
7 8 1 0 0 0 0
7 17 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
9 11 2 0 0 0 0
9 20 1 0 0 0 0
10 11 1 0 0 0 0
10 21 1 0 0 0 0
11 22 1 0 0 0 0
12 13 1 0 0 0 0
13 23 1 0 0 0 0
13 24 1 0 0 0 0
13 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
[(E)-3-phenylprop-2-enyl] acetate
4.2 InChl
InChI=1S/C11H12O2/c1-10(12)13-9-5-8-11-6-3-2-4-7-11/h2-8H,9H2,1H3/b8-5+
4.3 InChlKey
WJSDHUCWMSHDCR-VMPITWQZSA-N
4.4 Canonical SMILES
CC(=O)OCC=CC1=CC=CC=C1
4.5 lsomeric SMILES
CC(=O)OC/C=C/C1=CC=CC=C1
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病